Skip to main content
Article Open Access

The crystal structure of bis(ferrocenecarboxylato-κ2O,O′)bis[4-(dimethylamino)pyridine-κN]copper(II) — acetonitrile(1/2), C40H44CuO4Fe2N6

  • , , and EMAIL logo
Published/Copyright: April 2, 2019

Abstract

C40H44CuO4Fe2N6, triclinic, P1̄ (no. 2), a = 7.4758(4) Å, b = 7.7447(5) Å, c = 16.2929(10) Å, α = 87.111(2)°, β = 85.196(2)°, γ = 89.736(2)°, V = 938.82(10) Å3, Z = 1, Rgt(F) = 0.0672, wRref(F2) = 0.1316, T = 150(2) K.

CCDC no.: 1902121

Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal:Blue block
Size:0.25 × 0.13 × 0.12 mm
Wavelength:Mo Kα radiation (0.71073 Å)
μ:1.37 mm−1
Diffractometer, scan mode:Bruker APEX-III CMOS, φ and ω
θmax, completeness:26.2°, 99%
N(hkl)measured, N(hkl)unique, Rint:3819, 3819, 0.064
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 3089
N(param)refined:246
Programs:SHELX [1], Diamond [2], Bruker [3]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
Cu10.5000000.5000000.5000000.0106(3)
Fe10.49974(11)0.53615(11)0.17113(5)0.0148(3)
O10.4377(6)0.7117(5)0.3866(3)0.0176(9)
O20.6355(5)0.4967(5)0.3874(2)0.0136(9)
N10.6848(7)0.6512(6)0.5384(3)0.0134(11)
N21.0485(7)0.9742(6)0.6395(3)0.0171(11)
N30.8868(14)0.2079(13)0.0418(6)0.079(3)
C10.6579(8)0.8233(7)0.5423(4)0.0145(13)
H10.5521450.8703350.5215360.017*
C20.7736(8)0.9354(8)0.5745(4)0.0163(13)
H20.7457421.0550020.5766250.020*
C30.9345(8)0.8695(7)0.6042(3)0.0133(12)
C40.9681(8)0.6920(8)0.5965(4)0.0160(13)
H41.0770120.6420110.6124560.019*
C50.8405(8)0.5922(7)0.5656(4)0.0138(13)
H50.8638430.4717870.5630920.017*
C61.2196(9)0.9130(9)0.6630(5)0.0282(16)
H6A1.3004681.0114600.6655790.042*
H6B1.2711920.8340610.6222210.042*
H6C1.2036820.8518800.7172510.042*
C71.0124(8)1.1594(8)0.6438(4)0.0208(14)
H7A1.0808491.2067040.6862370.031*
H7B0.8838761.1775980.6578330.031*
H7C1.0482351.2179580.5902840.031*
C80.5558(7)0.6218(7)0.3505(3)0.0116(12)
C90.6085(8)0.6575(8)0.2615(3)0.0140(13)
C100.5246(9)0.7809(8)0.2100(4)0.0209(15)
H100.4234680.8591300.2277850.025*
C110.6071(10)0.7732(9)0.1295(4)0.0269(17)
H110.5722380.8433740.0801440.032*
C120.7417(9)0.6433(9)0.1290(4)0.0252(16)
H120.8202000.6083170.0798930.030*
C130.7460(8)0.5723(9)0.2119(4)0.0193(15)
H130.8287760.4799670.2312790.023*
C140.3558(10)0.3350(10)0.2281(4)0.0276(16)
H140.3550280.2956150.2875660.033*
C150.2391(9)0.4590(10)0.1942(5)0.0296(17)
H150.1421430.5235220.2257780.036*
C160.2846(10)0.4779(10)0.1077(5)0.0309(17)
H160.2254930.5567910.0676970.037*
C170.4283(10)0.3628(9)0.0887(4)0.0265(17)
H170.4897270.3470990.0326560.032*
C180.4715(10)0.2757(9)0.1627(4)0.0224(15)
H180.5685470.1875020.1678560.027*
C190.9713(14)0.1213(13)0.0828(6)0.053(2)
C201.0770(13)0.0124(12)0.1332(5)0.056(3)
H20A1.002826−0.0830030.1587460.084*
H20B1.1222690.0798680.1763950.084*
H20C1.178370−0.0342900.0991690.084*

Source of material

Ferrocenecarboxylic acid (0.069 g, 0.3 mmol) was dissolved in a methanol solution (6 mL) of Cu(CH3CN)4BF4 (0.095 g, 0.3 mmol) under ultrasonication. To the resulting yellow solution triethylamine (42 μL, 0.3 mmol) was added, after 10 min 4-(dimethylamino)pyridine (DMAP) (0.122 g, 0.6 mmol) was added under ultrasonication. The cloudy mixture was sealed and heated to 70 °C for 20 h. After cooled to room temperature, it was filtered, and the filtrate was evaporated at 5 °C. After 2 weeks, blue block crystals of title complex formed.

Experimental details

All hydrogen atoms were positioned geometrically and allowed to ride on their parent atoms.

Comment

Heterometallic complexes have been widely applied for medical use [4], [5]. Although ferrocene and its derivatives are popular molecules for biological applications [6], [7], there are few examples of heterometallic complexes to be used in medical useage. Preparation and revelation of heterometallic complexes constructed by reaction of ferrocene derivatives with other metals [8], [9] are the key problems for their application in medical use.

Here, we mix ferrocenecarboxylic acid (FcCOOH) with Cu(CH3CN)BF4 under the assistance of 4-(dimethylamino)pyridine (DMAP) to get the title complex. The asymmetric unit contains 0.5 copper ions, one ferrocenecarboxylato(-1), one DMAP and one free CH3CN. In the mononuclear title complex, the CuII ion, located on a crystallographic inversion centre, is six coordinated by two N atoms of two DMAP ligands in apical positions and four O atoms from two symmetry-related FcCOO, which are asymmetrically bonded in the equatorial plane. This coordination is very similar to the complexes bis(CH3COO–κ2O,O′)bis(DMAP)copper(II) [10], bis(CH3COO–κ2O,O′)bis(DMAP)copper(II) [11], and bis[ethyl(trifluoroacetyl)acetato-κ2O,O′]bis(DMAP)] copper(II) [12].

Award Identifier / Grant number: 21765008

Funding source: Natural Science Foundation of Guangxi

Award Identifier / Grant number: 2017GXNSFBA198178

Award Identifier / Grant number: 2016GXNSFBA380002

Funding source: Middle-aged and Young Teachers Basic Ability Promotion Project of Guangxi

Award Identifier / Grant number: 2017KY0649

Funding statement: We thank the National Natural Science Foundation of China (21765008), Natural Science Foundation of Guangxi (2017GXNSFBA198178, 2016GXNSFBA380002), the Middle-aged and Young Teachers Basic Ability Promotion Project of Guangxi (2017KY0649).

References

1. Sheldrick, G. M.: A short history of SHELX. Acta Crystallogr. A64 (2008) 112–122.10.1107/S0108767307043930Search in Google Scholar PubMed

2. Brandenburg, K.: DIAMOND. Visual Crystal Structure Information System. Version 3.2i. Crystal Impact, Bonn, Germany (2012).Search in Google Scholar

3. Bruker. APEX3 and SAINT. Bruker AXS Inc., Madison, WI, USA (2012).Search in Google Scholar

4. Nieto, D.; Bruña, S.; González-Vadillo, A. M.; Perles, J.; Carrillo-Hermosilla, F.; Antiñolo, A.; Padrón, J. M.; Plata, G. B.; Cuadrado, I.: Catalytically generated ferrocene-containing guanidines as efficient precursors for new redox-active heterometallic platinum(II) complexes with anticancer activity. Organometallics 34 (2015) 5407–5417.10.1021/acs.organomet.5b00751Search in Google Scholar

5. González-Pantoja, J. F.; Stern, M.; Jarzecki, A. A.; Royo, E.; Robles-Escajeda, E.; Varela-Ramírez, A.; Aguilera, R. J.; Contel, M.: Titanocene-phosphine derivatives as precursors to cytotoxic heterometallic TiAu2 and TiM (M = Pd, Pt) compounds. studies of their interactions with DNA. Inorg. Chem. 50 (2011) 11099–11110.10.1021/ic201647hSearch in Google Scholar

6. Patra, M.; Gasser, G.: The medicinal chemistry of ferrocene and its derivatives. Nat. Rev. Chem. 1 (2017) 1–12.10.1038/s41570-017-0066Search in Google Scholar

7. Ornelas, C.: Application of ferrocene and its derivatives in cancer research. New J. Chem. 35 (2011) 1973–1985.10.1039/c1nj20172gSearch in Google Scholar

8. Liu, K. G.; Shan, Q. D.; Nie, J.; Yan, X. W.: A 2D supramolecular network based on aromatic π⋯π stacking interactions. Z. Anorg. Allg. Chemie 644 (2018) 82–85.10.1002/zaac.201700377Search in Google Scholar

9. Liu, K. G.; Wang, R.; Han, H. Y.; Nie, J.; Yan, X. W.: Incorporating ferrocenecarboxylato(-1) into a [CuI2(μ-dppm)2]2+ (dppm = bis(diphenylphosphino)methane) scaffold for hydrogen peroxide sensing. J. Coord. Chem. 71 (2018) 3500–3509.10.1080/00958972.2018.1521966Search in Google Scholar

10. Benslimane, M.; Merazig, H.; Daran, J.: Bis(acetato-κ2O,O′)bis[4-(dimethylamino)pyridine-κN]copper(II). Acta Crystallogr. E67 (2011) m235.10.1107/S1600536811002017Search in Google Scholar PubMed PubMed Central

11. Fomina, I.; Dobrokhotova, Z.; Aleksandrov, G.; Bogomyakov, A.; Fedin, M.; Dolganov, A.; Magdesieva, T.; Novotortsev, V.; Eremenko, I.: Influence of the nature of organic components in dinuclear copper(II) pivalates on the composition of thermal decomposition products. Polyhedron 29 (2010) 1734–1746.10.1016/j.poly.2010.02.021Search in Google Scholar

12. Patev, N.; Císařová, I.; Zdravkova, M.; Vohlídal, J.: Structure of bis[ethyl(trifluoroacetyl)acetato]copper(II) and its adduct with 4-(dimethylamino)pyridine: EPR and X-ray study. J. Mol. Struct. 689 (2004) 191–197.10.1016/j.molstruc.2003.10.045Search in Google Scholar

Received: 2019-01-14
Accepted: 2019-03-09
Published Online: 2019-04-02
Published in Print: 2019-06-26

© 2019 Su-Juan Wang et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 Public License.

Articles in the same Issue

  1. Frontmatter
  2. Crystal structure of (E)-2-(1-((2-aminophenyl)imino)ethyl)-5-fluorophenol, C14H13FN2O
  3. Crystal structure of (E)-2-(1-((2-aminophenyl)imino)ethyl)-4,6-dichlorophenol, C14H12Cl2N2O
  4. The crystal structure of (E)-1-(4-methoxyphenyl)-3-(2-nitrophenyl)triaz-1-ene C8H8N2O4
  5. Crystal structure of (E)-2-(((6-bromopyridin-2-yl)methylene)amino)-3′,6′-bis(ethylamino)-2′,7′-dimethylspiro[isoindoline-1,9′-xanthen]-3-one—methanol (1:1), C32H30N5O2Br ⋅ CH4O
  6. Crystal structure of 2,4-pentanedione bis(2,4-dinitrophenylhydrazone), C17H16N8O8
  7. Crystal structure of sodium morpholine-4-carbodithioate, (C5H12NNaO3S2)
  8. Crystal structure of 1,1′-(hexane-1,6-diyl)bis(3-ethyl-1H-imidazol-3-ium) bis(hexafluorido phosphate), C16H28F12N4P2
  9. Crystal structure of 5-(4-chlorophenyl)-3-(4-fluorophenyl)-1-phenyl-4,5-dihydro-1H-pyrazole, C21H16ClFN2
  10. Crystal structure of catena-poly[diaqua-bis(3-carboxy-5-methoxybenzoato-κO)-(1,2-bis(imidazol-1-yl)ethane-κ2N:N′)cobalt(II)], C26H28CoN4O12, [Co(C9H6O5)2(H2O)2(C8H10N4)]
  11. The crystal structure of 3-cyclohexyl-1,5-dioxaspiro[5.5]undecane-2,4-dione, C15H22O4
  12. Crystal structure of (2,4-dimethoxybenzyl)triphenylphosphonium trifluoroacetate — trifluoroacetic acid (1/1), C31H27F6O6P
  13. Crystal structure of 4-tert-butyl-1-(2,6-dimethylphenyl)-1H-1,2,3-triazole, C14H19N3
  14. Crystal structure of 1,1′-methylenebis(4-tert-butylpyridinium) tetrachloridocobaltate(II) – dichloromethane (1:1), C20H30Cl6CoN2
  15. Crystal structure of (4,4′-(ethane-1,2-diylbis((nitrilo)(2-furylmethylylidene)))bis(3-methyl-1-phenyl-1H-pyrazol-5-olato-κ4N,N′,O,O′))-nickel(II)), C32H26N6NiO4
  16. Synthesis and crystal structure of bis{((E)-((4-((E)-1-(benzyloxyimino)ethyl)phenyl)imino)methyl)-2-phenolato-κ2N,O}copper(II), C44H38CuN4O4
  17. Crystal structure of catena-poly[diaqua-bis(3,5-dichloropyridine-4-carboxylato-κ1O)-bis(μ2-4,4′-bipyridine-κ2N:N′)cobalt(II)], C22H16Cl4CoN4O6
  18. The crystal structure of 2-(4-chloro-2,6-dinitrophenyl)-1-(4-chloro-3,5-dinitrophenyl)diazene 1-oxide, C12H4Cl2N6O9
  19. The crystal structure of 3-(1H-benzo[d]imidazol-2-yl)-7-chloro-1-cyclopropyl-6-fluoro-1,4-dihydroquinolin — dimethylsulfoxide (1/1), C21H19ClFN3O2S
  20. The crystal structure of dichlorido-bis(1-butyl-1H-imidazole-κN)zinc(II), C14H24Cl2ZnN4
  21. (Z)-N-tert-butyl-1-(2-(3,5-dichlorobenzamido)phenyl) methanimine oxide, C18H18Cl2N2O2
  22. Crystal structure of diaqua-bis(3-carboxy-5-bromoisophthalato-κO)-bis(1-(3-(1H-benzo[d]imidazol-1-yl)propyl)-1H-benzo[d]imidazol-3-ium-κN)nickel(II) bis(3-carboxy-5-bromoisophthalate), C66H54Br4N8NiO18
  23. Crystal structure of poly[aqua(μ2-5-methoxyisophthalato-κ2O,O′:O′′)-(1,2-bis(imidazol-1′-yl)ethane-κ2N:N′)cobalt(II), C34H36Co2N8O12
  24. Crystal structure of poly[diaqua-bis(μ2-1-(4-(1H-imidazol-1-yl)benzyl)-1H-1,2,4-triazole-κ2N:N′)manganese(II)] terephthalate tetrahydrate, MnC32H38N10O10
  25. Crystal structure of the fluorescent fipronil derivative 5,5′-(methylenebis(azanediyl))bis(1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-4-((trifluoromethyl)sulfinyl)-1H-pyrazole-3-carbonitrile), C25H6N8O2Cl4F12S2
  26. Crystal structure of the phosphorescent complex diethyldithiophosphonato-κ2S,S′-bis(2-phenylpyridinato-κ2C,N)iridium(III), C26H26N2O2PS2Ir
  27. The crystal structure of 4,10-diethoxy-6H,12H-6,12-epoxydibenzo[b,f][1,5]dioxocine, C18H18O5
  28. Crystal structure of dichlorido-bis(N-benzyl-2-(quinolin-8-yloxy)acetamide-κ2N,O)copper(II) — ethyl acetate (1/1), C38H36N4O6Cl2Cu
  29. Synthesis and crystal structure of bis{4-methyl-2-((E)-((4-((E)-1-(benzyloxyimino)ethyl)phenyl)imino)methyl)phenolato-κ3N,O,O}copper(II), C92H84Cu2N8O8
  30. The crystal structure of 1,3,5-trinitro-4,6-diazidobenzene, C6HN9O6
  31. Crystal structure 1-cinnamyl-2-((Z)-styryl)-1H-benzo[d]imidazole — methanol (1/1), C24H20N2 ⋅ CH4O
  32. The crystal structure of poly[m2-aqua-tetraaqua-bis(m9-4-formylbenzene-1,3-disulfonato)tetrasodium(I) hydrate, C14H18O19S4Na4
  33. Crystal structure of 2-((2,8-bis(trifluoromethyl)quinolin-4-yl)(hydroxy)methyl)piperidin-1-ium trifluoroacetate, [C17H17F6N2O][C2F3O2]
  34. The crystal structure of bis(ferrocenecarboxylato-κ2O,O′)bis[4-(dimethylamino)pyridine-κN]copper(II) — acetonitrile(1/2), C40H44CuO4Fe2N6
  35. Crystal structure of poly[di-μ2-aqua)-diaqua-bis(μ6-4,4′,4′′-(benzene-1,3,5-triyltris(oxy))tribenzoato-κ6O1:O2:O3:O3:O5:O6)tricadmium(II)] dihydrate, C54H42Cd3O24
  36. The crystal structure of dichlorido(1,3-bis(2,6-diisopropyl-phenyl)-1H-3λ4-imidazol-2-yl)(3-phenyl-pyridine-κN)palladium(IV), C38H45N3Cl2Pd
  37. The crystal structure of 2-chloro-4-(prop-2-yn-1-yloxy)-6-phenyl-1,3,5-triazine, C12H8ClN3O
  38. The crystal structure of 2,6-di-tert-butyl-4-(phenyl(phenylsulfonyl)methyl)phenol, C27H32O3S
  39. Crystal structure of bis{μ2-bis{(((((1-methoxyimino)ethyl)phenyl)imino)methyl)-2-phenolato-κ3N,O:O}copper(II)}, C68H68Cu2N8O8
  40. Crystal structure of catena-poly[tetraaqua-bis(μ2-2-(4-carboxylatophenoxy)benzoato-κ2O:O′)-pentakis(pyridine-κ1N)dinickel(II)], C53H47N5Ni2O13
  41. Synthesis and crystal structure of 1-(2,6-dichloro-4-trifluoromethyl-phenyl)-5-(3-methoxy-benzylamino)-4-trifluoromethanesulfinyl-1H-pyrazole-3-carbonitrile, C20H12N4Cl2F6O2S
  42. Redetermination of the crystal structure of bis(μ2-di-ethyldithiocarbamato-κ3S,S′:S3S:S: S′)-hexacarbonyl-di-rhenium(I), C16H20N2O6Re2S4
  43. The crystal structure of (E)-N′-((2-hydroxynaphthalen-1-yl)methylene)-2-phenylacetohydrazide, C19H16O2N2
  44. Crystal structure of 6-hydroxy-4,8,11b-trimethyltetradecayhdro-8,11-epoxy-6a,9-methanocyclohepta[a]naphthalene-4-carboxylic acid – methanol (1/1), C20H30O4
  45. The crystal structure of aqua-bis(3-acetyl-2-oxo-2H-chromen-4-olato-κ2O,O′)zinc(II) monohydrate, C22H18O10Zn
  46. Crystal structure of poly[bis(μ2-4-bromoisophthalate-κ2O:O′)-tris(μ2-1-(3-((1H-1,2,4-triazol-1-yl)methyl)benzyl)-1H-1,2,4-triazole-κ2N:N′)dicobalt(II)] monohydrate, C26H23CoN9O5Br
  47. A cyclic I102− anion in the layered crystal structure of theophyllinium pentaiodide, C7H9I5N4O2
  48. Crystal structure of catena-poly[diaqua-bis(μ2-4-((4-(pyridin-2-ylmethoxy)phenyl)diazenyl)benzoato-κ3O,O′:N)cadmium(III)], Cd(C19H14O3N3)2(H2O)
  49. Crystal structure of catena-poly[(μ2-4,4′-bipyridyl-κN,N′)-bis(O,O′-dimethyldithiophosphato-κS)-zinc(II)], {C14H20N2O4P2S4Zn}n
  50. Crystal structure of 3-amino-2-hydroxy-6-methoxybenzamide hydrate, C16H22N4O7
  51. Crystal structure of hemikis(cyclohexane-1,4-diammonium) (pyridine-2-carboxylate), [C6H16N2]0.5[C6H4NO2]
  52. Crystal structure of 2-chloro-4-(prop-2-yn-1-yloxy)-6-(thiophen-2-yl)-1,3,5-triazine, C10H6ClN3OS
  53. The crystal structure of 3-butyl-1-methyl-1H-imidazol-3-ium catena-poly[tris(μ2-bromido-κ2Br:Br)lead(II)], C8H15Br3N2Pb
  54. Crystal structure of 3-(5-amino-1H-1,2,4-triazol-3-yl)-1-(piperidin-1-yl)propan-1-one, C10H17N5O
  55. Crystal structure of aqua-2,2′,2′′-(((nitrilo-κN-tris(ethane-2,1-diyl))tris(azanylylidene-κ3N′,N′′,N′′′))tris(methanylylidene))tris(4-chlorophenolato-κ3O,O′,O′′)neodymium(III), C27H26Cl3N4NdO4
  56. Crystal structure of dichlorido-(μ2-2,2′-(diazene-1,2-diyl)bis(benzen-1-ido)-κ2C:C′)dimercury(II), C12H8Cl2Hg2N2
  57. Crystal structure of (3E,5E)-3,5-bis(4-cyanobenzylidene)-1-((4-fluorophenyl)sulfonyl)piperidin-4-one, C27H18FN3O3S
  58. Crystal structure of dichlorido(pyridine-κN)(2,4,6-tri-2-pyridyl-1,3,5-triazine-κ3N2,N1,N6)nickel(II), C23H17Cl2N7Ni
  59. Redetermination of the crystal structure of tetrakis(4-chlorobenzyl)tin(IV), C28H24Cl4Sn
  60. The crystal structure of 2,6-bis(pyridin-1-ium-3-ylmethyl)hexahydro-4,8-ethenopyrrolo-[3,4-f] isoindole-1,3,5,7-tetrone tetrachloridocuprate(II) monohydrate, C24H24Cl4CuN4O5
  61. Crystal structure of cyclo-[octaaqua-tetrakis(μ2-5,5′-(1H-imidazole-4,5-diyl)bis(tetrazol-2-ido)-κ4N,N′,N′′,N′′′)tetramagnesium(II)], C20H24N40O8Mg4
  62. The crystal structure of a matrine derivative, 13-(4-Cl-pyrrole)-matrine, C18H26ClN4O
  63. Crystal structure of (dibenzyl sulphoxide-κO)bis(2-chlorobenzyl-κC1)dichloridotin(IV), C28H26Cl4OSSn
  64. Crystal structure of catena-poly[(μ2-azido-κ2N:N)(μ2-4-cyanobenzoato-κ2O:O′)-(μ2-methanol-κ2O:O)copper(II)], C9H8CuN4O3
  65. Crystal structure of 1,1′-dibenzyl-3,3′-dicyano-1,1′,4,4′-tetrahydro-4,4′-bipyridine, C26H22N4
  66. Crystal structure of (2-bromobenzyl)((1-bromonaphthalen-2-yl)methyl)sulfane, C18H14Br2S
  67. Crystal structure of 2-(4-ammoniocyclohexyl)-3-(pyridin-2-yl)imidazo[1,5-a]pyridin-2-ium 2-[(2-carboxylatophenyl)disulfanyl]benzoate dihydrate, [C18H22N4][C14H8O4S2] ⋅ 2H2O
  68. Crystal structure of (E)-N-((3R,5S,10S, 13S,14S,17S)-17-((S)-1-(dimethylamino)ethyl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-3-yl)-2-methylbut-2-enamide – water – methanol (1/1/1), C29H54N2O3
  69. Crystal structure of methyl 2-(4-(3-(2,4-difluorophenyl)pyrazolo[1,5-a]pyrimidin-6-yl)phenyl)acetate, C21H15F2N3O2
  70. Crystal structure of poly[triaqua-(μ4-benzene-1,3,5-tricarboxylato-κ5O1,O2:O3:O4:O5)-(μ2-5-(3-pyridyl)tetrazolato-κ2N1:N3)dizinc(II)], C15H13N5O9Zn2
  71. Crystal structure of N-(3-methylphenyl)(propan-2-yloxy)carbothioamide, C11H15NOS
  72. Crystal structure of poly[(μ2-1,3-bis(imidazol-1-ylmethyl)benzene-κ2N:N′)(nitrato-κ1O)cadmium(II)] — water (2/1), C28H32CdN10O7
  73. Crystal structure of 4-phenyl-2,4-dihydro-3H-1,2,4-triazole-3-thione, C8H7N3S
  74. Crystal structure of benzyltrichloridobis(1H-pyrazole-κ2N)tin(IV), C13H15Cl3N4Sn
  75. Crystal structure of chlorido-4-fluorobenzyl-bis(2-methylquinolin-8-olato-κ2N,O)tin(IV), C27H22ClFN2O2Sn
  76. Crystal structure of tetrakis(O,O′-diisopropyldithiophosphato-κ2S,S′)-(μ2-1,2-bis(4-pyridylmethylene)hydrazine-κ2N:N′)zinc(II), C36H66N4O8P4S8Zn2
  77. Crystal structure of tetrabutylammonium 4,4-oxydibenzoate – boric acid – water (1/2/6) C46H98B2N2O17
  78. Redetermination of the crystal structure of catena-poly[[tribenzyltin(IV)]-(μ2-pyridine-4-carboxylato-κ2N:O)], C27H25NO2Sn
  79. The synthysis and crystal structure of cyclohexyl 5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-4-((trifluoromethyl)sulfinyl)-1H-pyrazole-3-carboxylate, C18H15N3Cl2F6O3S
  80. The crystal structure of 5,7-bis(2-hydroxyethoxy)-2-phenyl-4H-chromen-4-one, C19H18O6
  81. Synthesis and crystal structure of (±)-Ethyl 5′-(difluoromethyl)-2-oxo-4′,5′-dihydrospiro[indoline-3,3′-pyrazole]-4′-carboxylate, C14H13F2N3O3
Downloaded on 12.5.2026 from https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2019-0038/html?lang=en
Scroll to top button